Comparative Dosimetry of Single and Hybrid (177)Lu, (161)Tb, and (90)Y in PSMA-Targeted Therapy.

Oni OM, Smith TAD

Open source

DOI
10.3390/diseases14090305
Published
2026 Aug 24
Container
Diseases (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diseases14090305,
  title = {Comparative Dosimetry of Single and Hybrid (177)Lu, (161)Tb, and (90)Y in PSMA-Targeted Therapy.},
  author = {Oni OM and Smith TAD},
  year = {2026},
  journal = {Diseases (Basel, Switzerland)},
  doi = {10.3390/diseases14090305},
  url = {https://doi.org/10.3390/diseases14090305}
}

RIS

TY  - JOUR
TI  - Comparative Dosimetry of Single and Hybrid (177)Lu, (161)Tb, and (90)Y in PSMA-Targeted Therapy.
AU  - Oni OM
AU  - Smith TAD
PY  - 2026
JO  - Diseases (Basel, Switzerland)
DO  - 10.3390/diseases14090305
UR  - https://doi.org/10.3390/diseases14090305
ER  - 

APA

OM, O., & TAD, S. (2026). Comparative Dosimetry of Single and Hybrid (177)Lu, (161)Tb, and (90)Y in PSMA-Targeted Therapy.. Diseases (Basel, Switzerland). https://doi.org/10.3390/diseases14090305

Source records